By Amanda Bronstad | December 20, 2018
In the most substantial ruling to come out of the litigation over opioids, U.S. District Judge Dan Polster adopted most of a magistrate judge's Oct. 5 report and recommendation allowing RICO and public nuisance claims to go forward against opioid companies.
By Michael Booth | December 7, 2018
A Beverly Hills doctor is seeking more than $22 million in damages from business intelligence giant Dun & Bradstreet, claiming the New Jersey-based company defamed him by falsely documenting an arrest for sending sexually explicit material to an undercover cop posing as a teenager.
New Jersey Law Journal | Analysis
By Michael H. Reed | December 5, 2018
Does the U.S. Supreme Court's decision in 'Bristol Myers Squibb' apply to class actions?
By Charles Toutant | December 4, 2018
The approval rejected an objection raised by attorneys general from five states, who argued it went against U.S. Supreme Court's guidance.
By Andrew Denney | November 28, 2018
The trial, which is before Manhattan Supreme Court Justice Barbara Jaffe, is the 11th regarding Johnson & Johnson's allegedly asbestos-laden talcum powder, which plaintiffs say is giving them cancer.
By Michael Booth | November 13, 2018
The state of New Jersey has filed a lawsuit against Janssen Pharmaceuticals claiming the company used deceptive practices in the sale of two powerful opioids, Nucynta and Nucynta ER. The company is denying those claims.
By Michael Booth | November 8, 2018
The lawsuit was filed on Wednesday in Passaic County Superior Court on behalf of Paula Costigan and her son, William DelGrosso, 14, who has been hospitalized for weeks with the illness.
By Amanda Bronstad | November 5, 2018
“A boundless expansion of tort doctrine.” “Puts the cart before the horse.” “Kicks the can down the road.” That's how opioid companies have described an Oct. 5 report and recommendation that refused to dismiss a bellwether case against them.
New Jersey Law Journal | Analysis
By Daniel W. Roslokken | November 2, 2018
Championing the plight of small employers regarding the cost of coverage, AHPs were to be “about more choice, more access and more coverage.”
New Jersey Law Journal | Analysis
By Jon Lomurro and Abbott Brown | October 25, 2018
A recent appellate decision may clear up the legal-practice minefield of the Affidavit of Merit Statute and the Patients First Act.
Presented by BigVoodoo
New Jersey Law Journal honors lawyers leaving a mark on the legal community in New Jersey with their dedication to the profession.
This conference aims to help insurers and litigators better manage complex claims and litigation.
Recognizing innovation in the legal technology sector for working on precedent-setting, game-changing projects and initiatives.
When you come to work for New Jersey Judiciary you will join an 8500-member strong TEAM that operates with the highest standards of independ...
Title: Legal Counsel Reports to: Chief Executive Officer (CEO) FLSA Status: Exempt, Full Time Supervisory Responsibility: N/A Location: Remo...
Blume Forte Fried Zerres and Molinari 1 Main Street Chatham, NJ 07945Prominent Morris County Law Firm with a state-wide personal injury prac...